Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives

Chinese Journal of Natural Medicines

Volumn 15, Issue 5, 2017, Pages 321-329

  SALMANI, Jumah Masoud Mohammad ^a   ZHANG, Xiao Ping ^a   JACOB, Joe Antony ^a   CHEN, Bao An ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Anticancer; Apigenin; Flavonoid; Mechanism of action

Indexed keywords

APIGENIN; DNA; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; PHYTOCHEMICAL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BLADDER CANCER; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DISEASE MODEL; DNA DAMAGE; DNA REPAIR; DRUG MECHANISM; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CANCER; MOUTH CANCER; NEOPLASM; PANCREAS CANCER; PHYTOCHEMISTRY; PROSTATE CANCER; SKIN CANCER; THYROID CANCER; UPREGULATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; APOPTOSIS; AUTOPHAGY; HUMANS; NEOPLASMS; PHYTOCHEMICALS;

EID: 85019741722     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(17)30052-3     Document Type: Article

References (50)

1. Newman, DJ, Cragg, GM, Natural products as sources of new drugs over the last 25 years [J]. J Nat Prod 70:3 (2007), 461–477.
2. Venigalla, M, Gyengesi, E, Münch, G, Curcumin and apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease [J]. Neural Regen Res 10:8 (2015), 1181–1185.
3. Shukla, S, Gupta, S, Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes [J]. Clin Cancer Res 10:9 (2014), 3169–3178.
4. Way, TD, Kao, MC, Lin, JK, Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells [J]. FEBS Lett 579:1 (2005), 145–152.
5. Nicholas, C, Batra, S, Vargo, MA, et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation [J]. J Immunol 179:10 (2007), 7121–7127.
6. Koo, H, Rosalen, PL, Cury, JA, et al. Effects of compounds found in propolis on streptococcus mutans growth and on glucosyltransferase activity [J]. Antimicrob Agents Chemother 46:5 (2002), 1302–1309.
7. Lv, X, Qiu, M, Chen, D, et al. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway [J]. Antiviral Res 109:1 (2014), 30–41.
8. Zhang, W, Qiao, H, Lv, Y, et al. Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors [J]. PLoS One, 9(10), 2014, e110429.
9. Singh, G, Kumar, P, Joshi, SC, Treatment of dermatophytosis by a new antifungal agent ‘apigenin’ [J]. Mycoses 57:8 (2014), 497–506.
10. Lee, JH, Zhou, HY, Cho, SY, et al. Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules [J]. Arch Pharm Res 30:10 (2007), 1318–1327.
11. Romanova, D, Vachalkova, A, Cipak, L, et al. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method [J]. Neoplasma 48:2 (2001), 104–107.
12. Pal, HC, Hunt, KM, Diamond, A, et al. Phytochemicals for the management of melanoma [J]. Mini Rev Med Chem 16:12 (2016), 953–979.
13. Liu-Smith, F, Meyskens, FL, Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma [J]. Mol Nutr Food Res 60:6 (2016), 1264–1274.
14. Nabavi, SM, Habtemariam, S, Daglia, M, et al. Apigenin and breast cancers: from chemistry to medicine [J]. Anticancer Agents Med Chem 15:6 (2015), 728–735.
15. Bao, YY, Zhou, SH, Fan, J, et al. Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers [J]. Future Oncol 9:9 (2013), 1353–1364.
16. Lefort, EC, Blay, J, Apigenin and its impact on gastrointestinal cancers [J]. Mol Nutr Food Res 57:1 (2013), 126–144.
17. Shukla, S, Gupta, S, Apigenin: a promising molecule for cancer prevention [J]. Pharm Res 27:6 (2010), 962–978.
18. Patel, D, Shukla, S, Gupta, S, Apigenin and cancer chemoprevention: Progress, potential and promise (Review) [J]. Int J Oncol 30:1 (2007), 233–245.
19. Qin, Y, Zhao, D, Zhou, HG, et al. Apigenin inhibits NF-kappaB and snail signaling, EMT and metastasis in human hepatocellular carcinoma [J]. Oncotarget 7:27 (2016), 41421–41431.
20. Seydi, E, Rasekh, HR, Salimi, A, et al. Selective Toxicity of apigenin on cancerous hepatocytes by directly targeting their mitochondria [J]. Anticancer Agents Med Chem 16:12 (2016), 1576–1586.
21. Hu, XY, Liang, JY, Guo, XJ, et al. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (DeltaPsim)-mediated apoptosis in hepatocellular carcinoma [J]. Clin Exp Pharmacol Physiol 42:2 (2015), 146–153.
22. Kim, EY, Yu, JS, Yang, M, et al. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5 [J]. Mol Cells 35:1 (2013), 32–40.
23. Noolu, B, Gogulothu, R, Bhat, M, et al. In vivo inhibition of proteasome activity and tumour growth by murraya koenigii leaf extract in breast cancer xenografts and by its active flavonoids in breast cancer cells [J]. Anticancer Agents Med Chem 16:12 (2016), 1605–1614.
24. 2/M arrest and histone H3 acetylation-mediated p21 expression [J]. Environ Toxicol 32:2 (2016), 434–444.
25. Seo, HS, Ku, JM, Choi, HS, et al. Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells [J]. Anticancer Res 34:6 (2014), 2869–2882.
26. Cao, X, Liu, B, Cao, W, et al. Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells [J]. Chin J Cancer Res 25:2 (2013), 212–222.
27. Kim, SH, Kang, JG, Kim, CS, et al. Suppression of AKT potentiates synergistic cytotoxicity of apigenin with trail in anaplastic thyroid carcinoma cells [J]. Anticancer Res 35:12 (2015), 6529–6537.
28. Zhang, L, Cheng, X, Gao, Y, et al. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells [J]. Food Funct 6:11 (2015), 3464–3472.
29. Xu, M, Wang, S, Song, YU, et al. Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/beta-catenin signaling pathway [J]. Oncol Lett 11:5 (2016), 3075–3080.
30. Chunhua, L, Donglan, L, Xiuqiong, F, et al. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT [J]. J Nutr Biochem 24:10 (2013), 1766–1775.
31. Wang, QR, Yao, XQ, Wen, G, et al. Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression [J]. Oncol Lett 2:1 (2011), 43–47.
32. Lee, Y, Sung, B, Kang, YJ, et al. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells [J]. Int J Oncol 44:5 (2014), 1599–1606.
33. Turktekin, M, Konac, E, Onen, HI, et al. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29) [J]. J Med Food 14:10 (2014), 1107–1117.
34. Shukla, S, Kanwal, R, Shankar, E, et al. Apigenin blocks IKKalpha activation and suppresses prostate cancer progression [J]. Oncotarget 6:31 (2015), 31216–31232.
35. Shukla, S, Fu, P, Gupta, S, Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70–Bax interaction in prostate cancer [J]. Apoptosis 19:5 (2014), 883–894.
36. Singh, V, Sharma, V, Verma, V, et al. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-beta from degradation and induce apoptosis in prostate cancer cells [J]. Eur J Nutr 54:8 (2015), 1255–1267.
37. Sharma, H, Kanwal, R, Bhaskaran, N, et al. Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells [J]. PLoS One, 9(3), 2014, e91588.
38. Pandey, M, Kaur, P, Shukla, S, et al. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study [J]. Mol Carcinog 51:12 (2012), 952–962.
39. Oishi, M, Iizumi, Y, Taniguchi, T, et al. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2 [J]. PLoS One, 8(2), 2013, e55922.
40. Shi, MD, Shiao, CK, Lee, YC, et al. Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis [J]. Cancer Cell Int 15:33 (2015), 1–12.
41. Wu, DG, Yu, P, Li, JW, et al. Apigenin potentiates the growth inhibitory effects by IKK-beta-mediated NF-kappaB activation in pancreatic cancer cells [J]. Toxicol Lett 224:1 (2014), 157–164.
42. Johnson, JL, de Mejia, EG, Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3beta/NF-kappaB signaling cascade [J]. Mol Nutr Food Res 57:12 (2013), 2112–2127.
43. Maggioni, D, Garavello, W, Rigolio, R, et al. Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis [J]. Int J Oncol 43:5 (2013), 1675–1682.
44. Das, S, Das, J, Samadder, A, et al. Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria [J]. Exp Biol Med 237:12 (2012), 1433–1448.
45. Choudhury, D, Ganguli, A, Dastidar, DG, et al. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin [J]. Biochimie 95:6 (2013), 1297–1309.
46. Lin, CC, Chuang, YJ, Yu, CC, et al. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo [J]. J Agric Food Chem 60:45 (2012), 11395–11402.
47. Gonzalez-Mejia, ME, Voss, OH, Murnan, EJ, et al. Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27 [J]. Cell Death Dis, 1, 2010, e64, 10.1038/cddis.2010.41.
48. Ruela-de-Sousa, RR, Fuhler, GM, Blom, N, et al. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy [J]. Cell Death Dis, 1, 2010, e19, 10.1038/cddis.2009.18.
49. Zhao, M, Ma, J, Zhu, HY, et al. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90 [J]. Mol Cancer, 10, 2011, 104, 10.1186/1476-4598-10-104.
50. Chan, LP, Chou, TH, Ding, HY, et al. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin [J]. Biochim Biophys Acta 1820:7 (2012), 1081–1091.